Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Launch innovative vitamin sublingual sprays
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Subscribe To Our Newsletter & Stay Updated
